Insights
In My Opinion
In Your Practice
Patient Populations
Topics
Cancer Types
Therapeutic Approaches
Side Effect Management
Diagnostics + Biomarkers
Podcasts
Videos
News
Conference Correspondent
Subscribe
Subscribe
Real Clinics. Real Patients. Real Oncology.
Home
/
News
ASCO 2026
Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care
Pembrolizumab plus chemotherapy is changing first-line care for advanced endometrial cancer, with NRG GY018 showing major progression-free survival gains across MMR status.
May 29, 2026
All
FDA Approvals
Cancer Types
All Cancer Types
Endometrial Cancer
Hematologic Malignancies
Leukemia
Lymphoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Prostate Cancer
Diagnostics + Biomarkers
Screening
All Diagnostics + Biomarkers
Screening
Therapeutic Approaches
Immunotherapy
All Therapeutic Approaches
Chemotherapy
Immunotherapy
Targeted Therapy
Clinical Trials
Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care
May 29, 2026
News
An Overview of a Study of Social Risk Factor Screening in Survivorship
April 10, 2026
What are you looking for?
Search
Popular Searches
Oncology
Practice Management
Navigation
